Key points:
- LG Chem will acquire AVEO Pharmaceuticals approximately $566 million
- The company will pay $15 per share
- AVEO stock surged over 40% on the news
South Korea’s LG Chem announced it is acquiring U.S. firm AVEO Pharmaceuticals for a deal worth approximately $566 million.
The deal will see LG Chem acquire AVEO for $15 per share, a roughly 43% premium from AVEO’s closing price on Monday, in an all-cash transaction.
AVEO shares rallied 40.46% following the announcement.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
The companies said the combination of the firms is expected to build a robust portfolio of innovative products.
The deal will extend LG Chem’s commercial footprint to the U.S., diversifying its pipeline with a broad range of oncology therapies and accelerating its efforts to deliver continued growth.
Also Read: Five Best Pharmaceutical Stocks To Watch In 2022
“With its track record of clinical success, deep pipeline of innovative therapies and continued growth trajectory following the successful commercialization of FOTIVDA, AVEO is the perfect partner for LG Chem Life Sciences,” said Shin Hak-Cheol, Chief Executive Officer of LG Chem.
Hak-Cheol added: “This transaction represents the next step in our portfolio transformation towards higher growth markets and provides a strong commercial foundation in oncology as we continue to develop our anti-cancer offerings.”
According to the company’s statement, LG Chem can harness its full potential in oncology through this transaction.
Elsewhere, AVEO expects to report its third-quarter financial results on November 7. However, following today’s news, AVEO will not conduct an earnings conference call or provide financial guidance.
Aveo stock has risen 120% in 2022.
